MYNZ — Mainz Biomed B.V.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for MYNZ in the TickerWise workspace.

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.

Company profile

• Sector: Healthcare
• Industry: Medical - Diagnostics & Research
• Country: DE
• Exchange: NASDAQ
• Employees: 19
• Website: https://mainzbiomed.com

Latest SEC filings for MYNZ

• 2026-10-09424B5
• 2026-07-093
• 2026-06-17EFFECT
• 2026-06-01ARS
• 2026-05-188-K
• 2026-05-1510-Q
• 2026-05-088-K
• 2026-04-288-K
• 2026-04-283
• 2026-04-158-K

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.